GETI.B

209.4

+0.29%↑

BIOAB

290

-7.29%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

BIOAB

290

-7.29%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

BIOAB

290

-7.29%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

BIOAB

290

-7.29%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

BIOAB

290

-7.29%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

Home・Akcijų sąrašas・Camurus AB

Camurus AB

Uždarymo kaina

723.5 -0.07

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

716

Max

730

Pagrindiniai rodikliai
By Trading Economics
Pajamos	53M 292M
Pardavimai	117M 676M
P/E Sektoriaus vid.	59.883 35.733
Pelnas, tenkantis vienai akcijai	4.08
Pelno marža	43.235
Darbuotojai	267
EBITDA	54M 315M

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	1.8B 43B
Ankstesnė atidarymo kaina	723.57
Ankstesnė uždarymo kaina	723.5

Camurus AB Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-09-05 16:09; UTC

Įsigijimai, susijungimai, perėmimai

BBVA Clears Last Hurdle to Open $17.4 Billion Bid to Sabadell Shareholders -- 2nd Update

2025-09-05 20:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-09-05 20:37; UTC

Įsigijimai, susijungimai, perėmimai

Blue Water: Assets of Auction Include Nationwide Retail Distribution Network of More Than 4,000 Branded Service Stations >BLUWU

2025-09-05 20:37; UTC

Įsigijimai, susijungimai, perėmimai

Blue Water: Assets of Auction Include Lubricant and Blending Plants Supporting Specialty Fuels and Lubricants >BLUWU

2025-09-05 20:36; UTC

Įsigijimai, susijungimai, perėmimai

Blue Water: Assets of Auction Include Midstream Infrastructure, Including Pipelines and Terminals Such as the Sour Lake Crude Pipeline >BLUWU

2025-09-05 20:36; UTC

Įsigijimai, susijungimai, perėmimai

Blue Water: Assets of Auction Include Refineries at Lake Charles, La., Lemont, Ill., Corpus Christi, Texas, With Combined Refining Capacity Exceeding 800,000 Barrels per Day >BLUWU

2025-09-05 20:33; UTC

Įsigijimai, susijungimai, perėmimai

Blue Water: Proposal Would Provide $3.2B Settlement for Holders of PDVSA 2020 Bonds to Be Paid Either in Cash or in Shrs of Publicly Listed Entity That Will Own Citgo >BLUWU

2025-09-05 20:33; UTC

Įsigijimai, susijungimai, perėmimai

Blue Water: Proposal Would Provide Cash or Stk Distributions to PDV Holding Inc.'s General Creditors >BLUWU

2025-09-05 20:31; UTC

Įsigijimai, susijungimai, perėmimai

Blue Water Acquisition Corp. III: Announces Submission of $10B Bid for PDV Holding Inc., Parent of Citgo Petroleum Corp.

2025-09-05 20:20; UTC

Uždarbis

These Stocks Moved the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

2025-09-05 19:23; UTC

Rinkos pokalbiai

Oil Futures Extend Losses Ahead of OPEC+ Meeting -- Market Talk

2025-09-05 19:22; UTC

Uždarbis

Week's Best: Insurance Costs, Like Sea Levels, Are Rising -- Barrons.com

2025-09-05 19:17; UTC

Rinkos pokalbiai

U.S. Natural Gas Snaps Winning Streak -- Market Talk

2025-09-05 18:59; UTC

Uždarbis

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

2025-09-05 18:35; UTC

Rinkos pokalbiai

BMO Leans Toward September Canada Rate Cut After 'Exceptionally Weak' Jobs Report -- Market Talk

2025-09-05 17:25; UTC

Rinkos pokalbiai

Bets on Hefty Fed Cut Seen as Exaggerated -- Market Talk

2025-09-05 17:20; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises By 2 to 414 -- Market Talk

2025-09-05 17:17; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-09-05 17:17; UTC

Rinkos pokalbiai

Bank of Canada Policy Seen Moving to Expansionary Territory -- Market Talk

2025-09-05 17:03; UTC

Rinkos pokalbiai

Bank of Canada Expected to Cut, But Inflationary Pressures Remain a Concern -- Market Talk

2025-09-05 16:39; UTC

Įsigijimai, susijungimai, perėmimai

Yorkville Acquisition: Commencing at Market Open on Sept 8, Common Stk Will Trade on Nasdaq Under New Ticker Symbol 'MCGA' >YORK

2025-09-05 16:39; UTC

Įsigijimai, susijungimai, perėmimai

Yorkville Acquisition: Will Be Renamed to Trump Media Group CRO Strategy Upon Closing of Combination Between Yorkville, Trump Media & Technology Group Corp. and Crypto.com >YORK

2025-09-05 16:39; UTC

Įsigijimai, susijungimai, perėmimai

Yorkville Acquisition Corp.: Announces Ticker Symbol Change to 'MCGA' Ahead of Trump Media Group CRO Strategy, Inc. Listing

2025-09-05 16:39; UTC

Įsigijimai, susijungimai, perėmimai

Yorkville Acquisition: Outstanding Publicly Traded Units and Warrants Will Trade on Nasdaq Under New Ticker Symbols 'MCGAU' and 'MCGAW', Respectively >YORK

2025-09-05 16:37; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Global Equities Roundup: Market Talk

2025-09-05 16:37; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Global Energy Roundup: Market Talk

2025-09-05 16:37; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Strathcona Buys Up More MEG Shares In Effort to Scuttle Cenovus Deal -- Market Talk

2025-09-05 16:20; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-09-05 16:16; UTC

Uždarbis

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Guidewire, and More -- Barrons.com

2025-09-05 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Camurus AB Prognozė

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Camurus AB

Camurus AB (publ), a biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence and chronic pain and Brixadi to treat opioid use disorder. Its products pipeline also includes CAM2038 for the treatment of chronic pain; CAM2029, which is in phase III clinical trials for the treatment of acromegaly and neuroendocrine tumors, as well as in phase II clinical trial to treat polycystic liver diseases; and CAM2043 that is in phase I clinical trial for the treatment of pulmonary arterial hypertension, as well as in Phase II clinical trial to treat Raynaud's phenomenon. In addition, the company is developing CAM2032, which is in phase II clinical trials for the treatment of prostate cancer; CAM4072 that is in phase III clinical trials for the treatment of genetic obesity disorders; CAM4071, which is in phase I clinical trials for the treatment of endocrine disorder; and CAM2047 that is in phase 1 clinical trial for the treatment of chemotherapy-induced nausea and vomiting. It has strategic partnerships with Braeburn Pharmaceuticals to develop CAM2038 for the treatment of opioid use disorder; and Rhythm Pharmaceuticals Inc. to develop CAM4072 for the treatment of a range of rare genetic disorders of obesity, as well as licensing agreement with Solasia Pharma. Camurus AB (publ) was founded in 1991 and is headquartered in Lund, Sweden.